Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial
2021 ◽
Vol 114
◽
pp. 105164
Peter Oppelt
◽
Jessica C. Ley
◽
Francis Worden
◽
Kevin Palka
◽
Ronald Maggiore
◽
...